1. Center for Substance Abuse Research. Number of First Time Non-Medical Users of Prescription Pain Relievers Remains at Peak Level, Rivaling Marijuana; Number of New Ecstasy Users Declines. College Park, Md: CESAR; 2004.
2. Cicero TJ, Inciardi JA, Munoz AS. Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002–2004. J Pain. 2005;6:662–672. [PubMed] 3. Novak S, Nemeth WC, Lawson KA. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med. 2004;5:59–65. [PubMed]
4. Substance Abuse and Mental Health Services Administration. Overview of Findings From the 2002 National Survey on Drug Use and Health (Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774) Rockville, Md: SAMHSA; 2003.
5. Substance Abuse and Mental Health Services Administration; Results From the 2003 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-25, DHHS Publication No. SMA 04-3964) Rockville, Md: SAMHSA; 2004.
6. Portenoy RK. In: Inadequate outcome of cancer pain treatment influences on patient and clinician behavior, in Problems in Cancer Pain Management. Patt RB, editor. New York: JB Lippincott; 1992. pp. 119–128.
7. Roth SH, Fleischmann RM, Burch FX, Dietz F, Bockow B, Rapoport RJ, Rutstein J, Lacouture PG. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853–860. [PubMed] 8. Passik SD. Responding rationally to recent reports of abuse/diversion of OxyContin. J Pain Symptom Manage. 2001;21:359. [PubMed] 9. Cone EJ, Fant RV, Rohay JM, Caplan YH, Ballina M, Reder RF, Haddox JD. Oxycodone involvement in drug abuse deaths, II: evidence for toxic multiple drug-drug interactions. J Anal Toxicol. 2004;28:217–225. [PubMed] 10. Cone EJ, Fant RV, Rohay JM, Caplan YH, Ballina M, Reder RF, Spyker D, Haddox JD. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol. 2003;27:57–67. [PubMed] 11. Drummer OH, Syrjanen ML, Phelan M, Cordner SM. A study of deaths involving oxycodone. J Forensic Sci. 1994;39:1069–1075. [PubMed] 12. White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94:961–972. [PubMed] 13. Roche T. The potent perils of a miracle drug. Time. 2001 Jan 8;:47. [PubMed]
14. Zack I. Pain in the asset. Forbes. 2001 Feb 5;:57.
15. OxyContin puts Appalachians in death grip. Enterprise-Journal; 2001. Jun 24,
16. Hilliard WM. OxyContin a “nuclear bomb”: police officer describes explosive growth of “OXY.” Telegram. 2004 Jun 20;
17. MD is found guilty of manslaughter. Miami Herald; 2006. Mar 7, p. 10B.
18. Man pleads guilty to murder in OxyContin death, faces up to 81 years in prison. Associated Press; 2001. Jul 24,
19. Camus T. OxyContin’s trail of sadness, dozens share grief of losing loved ones to addictive drug. Halifax Herald Limited. 2004 Apr 1;
20. Chachere V. Prescription painkiller death for one, manslaughter charges for friends. Associated Press; 2001. Jun 4,
21. Clines FX, Meier B. Cancer painkillers pose new abuse threat. New York Times; 2001. Feb 9, p. 1.
22. Jewett C. New generation of addiction: youths’ deadly abuse of the drug OxyContin shows an alarming rise, area health officials say. Sacramento Bee. 2005 Jan 17;
23. Meier B. Overdoses of painkiller are linked to 282 deaths. New York Times; 2001. Oct 28,
24. Meier B. Doctor to face U.S. charges in drug case. New York Times; 2001. Dec 23,
25. Tough P. The alchemy of OxyContin. New York Times; 2001. 29,
26. Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004;73:199–207. [PubMed] 27. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302:123. [PubMed] 28. Carise D, McLellan AT, Gifford LS, Kleber HD. Developing a national addiction treatment information system: An introduction to the Drug Evaluation Network System. J Subst Abuse Treat. 1999;17:67–77. [PubMed] 29. Carise D, McLellan AT, Cacciola J, Love M, Cook T, Bovasso G, Lam V. Suggested specifications for a standardized Addiction Severity Index database. J Subst Abuse Treat. 2001;20:239–244. [PubMed] 30. Carise D, McLellan AT, Festinger DS, Kleber HD. Identifying United States substance abuse treatment programs: a test in one mid-sized city. Subst Abus. 2005;25:21–28. [PubMed]
31. Carise D, Gurel O. In: Benefits of integrating assessment technology with treatment: The Drug Evaluation Network System project, in Drug Abuse Treatment Through Collaboration: Practice and Research Partnerships That Work. Sorenson J, Rawson RA, Guydish J, Zweben J, editors. Washington, DC: American Psychological Association; 2003. pp. 181–195.
32. Institute of Medicine: Broadening the Base of Treatment for Alcohol Problems. Vol. 1990. Washington, DC: National Academy Press;
33. McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26–33. [PubMed] 34. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, O’Brien CP. New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis. 1985;173:412–423. [PubMed] 35. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199–213. [PubMed] 36. Fureman I, McLellan AT, Alterman A. Training for and maintaining interviewer consistency with the ASI. J Subst Abuse Treat. 1994;11:233–237. [PubMed] 38. McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public’s demand for quality care? J Subst Abuse Treat. 2003;25:117–121. [PubMed]
39. Meyers KM, McLellan AT. In: The American treatment system for adolescent substance abuse: formidable challenges, fundamental revisions, and mechanisms for improvements, in Treating and Preventing Adolescent Mental Health Disorders: What We Know and What We Don’t Know, A Research Agenda for Improving the Mental Health of Our Youth. Evans DL, Foa EB, Gur RE, Hendin H, O’Brien CP, Seligman MEP, Walsh BT, editors. New York: Oxford University Press; 2005.
40. Bloodsworth D. Powerful drug for minor backache starts newlywed’s downward spiral. Orlando Sentinel; 2003. Oct 19, p. A1.
41. Bloodsworth D. Free from addiction, man ready to start over. Orlando Sentinel; 2003. Oct 23, p. A1.
42. Bloodsworth D. OxyContin maker says patient is not credible, ex-cop profiled in articles had drug-related conviction. Orlando Sentinel; 2004. Feb 1, p. B1.
43. Fischman J. OxyContin abuse overstated. US News and World Report. 2003 March 1;
44. Katz DA, Hays LR. Adolescent OxyContin abuse. J Am Acad Child Adolesc Psychiatry. 2004;43:231–234. [PubMed]
45. Federal Register: Qualifying Urban Areas for Census 2000. College Park, Md: Office of the Federal Register, NARA; 2002. pp. 21961–21967.